RENALuT is a phase 2, single-arm trial evaluating the efficacy of [177Lu]Lu-PSMA-617 in patients with second- or third-line metastatic clear cell renal cell carcinoma (ccRCC). The study explores a ...
In a world saturated with stories—from ancient myths to TikTok clips—narratives knit together emotion, memory, and meaning. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback